Hematology & Oncology

Metabolic Syndrome and Obesity Up Risk of Mortality in CRC

Obese patients with metabolic syndrome have increased risk of all-cause, CRC-related death

New Anticancer Drugs Up Costs and Life Expectancy Considerably

Lifetime costs up $72,000, life expectancy up 13 months with new drug use in breast cancer

Similar NSCLC Survival for Surgical, Endosonographic Staging

Five-year survival not significantly different after mediastinoscopy or endosonographic staging

Neoadjuvant Chemotherapy Use Up in Ovarian Cancer Treatment

NACT use up from 2003 to 2012; linked to shorter overall survival in stage IIIC but not stage IV disease

Levonorgestrel IUD Potentially Cost-Effective in Obese Women

Intrauterine device is potentially cost-effective for prevention of deaths from endometrial cancer

Pregnancy Screens Lacking for Teens With Leukemia

Low rates for teens with acute leukemia and ER visits before teratogenic exposures